Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine and Pravastatin with Mitoxantrone and Etoposide for Relapsed/Refractory AML
NCT01342887Phase 2Terminated
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Apr 2011
- Primary completion
- Mar 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine, pravastatin in acute myeloid leukemia (AML), sponsored by Fred Hutchinson Cancer Center. Started Apr 2011; status: terminated.
02
Drugs
cyclosporinepravastatin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01342887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01342887.